Collects survey data from people with type 1 diabetes and their supporters
Gathers yearly survey information from people with type 1 diabetes and their supporters.
Key facts
- Who runs it
- T1D Exchange, United States
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- The T1D Exchange Registry
- Status
- Recruiting
- People taking part
- 50,000 people, planned
- Started
- 13 Dec 2018
- Expected to end
- 31 Dec 2030
- Type of study
- Observational
- Record updated
- 8 May 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people living in the United States who have type 1 diabetes. They must read and understand English.
- Age
- No age limit is stated. People younger than 18 years need parent or guardian consent.
- Sex
- All sexes can join.
- Disease stage
- A clinical diagnosis of type 1 diabetes.
- Earlier treatment
- People who do not use insulin cannot join, unless they have had a pancreatic or islet cell transplant.
Main reasons for not taking part
- Does not use insulin and has not had a pancreatic or islet cell transplant
- Cannot fully read and understand English
- Does not currently live in the United States
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Clinical diagnosis of type 1 diabetes
- Individuals younger than 18 years of age must have parent/guardian consent
- Must be able to read and understand English
- Currently living in the United States
Who cannot take part
- Does not use insulin and has not had a pancreatic or islet cell transplant
- Cannot fully read and understand English
- Does not currently live in the United States
Where in United States
- T1D ExchangeBoston, United StatesContact: Kelsie LaFerriereTaking people
About the trial
What the trial wants to find out
The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity to sign up for other studies on various topics related to type 1 diabetes.
Read full original descriptionShow less
To participate, you will be asked to:
* Read and sign an online informed consent form * Take a survey describing specific demographic and type 1 diabetes management information * Update your information annually * Periodically opt in for additional research opportunities (if you choose), i.e. taking new surveys or uploading health device data
The group in the trial
- Individuals diagnosed with type 1 diabetes
T1D Exchange Registry is currently looking for participants: * Of all ages, genders, races, and ethnic groups * Living in the United States * Diagnosed with type 1 diabetes * Currently taking insulin or have had a pancreatic or islet cell transplant
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The T1D Exchange Registry
- Plain-language title
- Collects survey data from people with type 1 diabetes and their supportersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 8 May 2023